Go to Maps
Go to Maps
+1 (321) 355-2686
ACCESS AND AFFORDABILITY
Strategic and tactical insights on pharmaceutical market access topics spanning distribution, pharmacy, and access and affordability.
Cell and Gene Therapy
1 day ago
Pharmaceutical Commercial Success Begins with Superior Strategic Planning
Webinar Archive: 11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
Best Practices for Improving Program Performance Through Well-Managed SP Relationships
Control vs. Access: Why Clinical Characteristics Should Guide Specialty Pharmacy Strategy
How Equitable is Your Pharmacy Dispensing Strategy?
How to Prepare for DSCSA D-Day
10 Steps to Building an Integrated Pharmaceutical Launch Strategy
How Patient Support Programs Can Compliantly Interact with Commercial Teams
Effective and Practical Ways to Impact Health Inequity Now
Want to Build a Market-Leading Pharmaceutical Patient Support Program? Ask a Nurse.
11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
How Quality in Patient Services Programs Can be a Powerful Differentiator for Pharma and Biotech
Maximizing Specialty Pharmacy Contracts
What the CMS Final Rule on Copay Programs Means for Pharmaceutical Manufacturers
Rare Disease Resources Every Pharma and Biotech Company Should Know
9 Considerations When Designing Your Specialty Pharmacy Network
Advice for New Patient Services Leaders
Dec 21, 2021
Happy New Year!
Dec 14, 2021
How to Maximize Relationships with Distribution Partners
Nov 30, 2021
5 Hurdles to Patient Support Program Success and How to Overcome Them
Nov 15, 2021
How Leading Pharma and Biotech Companies Ensure Vendor QBRs are Meaningful
Nov 2, 2021
6 Market Access Mistakes Cell and Gene Therapy Companies Make
Oct 19, 2021
A Total Solution to Your Market Access Needs
Oct 5, 2021
Are Pharma and Biotech Companies Asking Potential 3PL Partners the Right Questions?